Michele Morari

6.1k total citations
124 papers, 4.5k citations indexed

About

Michele Morari is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Michele Morari has authored 124 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Cellular and Molecular Neuroscience, 66 papers in Molecular Biology and 48 papers in Neurology. Recurrent topics in Michele Morari's work include Neuroscience and Neuropharmacology Research (58 papers), Receptor Mechanisms and Signaling (41 papers) and Parkinson's Disease Mechanisms and Treatments (38 papers). Michele Morari is often cited by papers focused on Neuroscience and Neuropharmacology Research (58 papers), Receptor Mechanisms and Signaling (41 papers) and Parkinson's Disease Mechanisms and Treatments (38 papers). Michele Morari collaborates with scholars based in Italy, Switzerland and United States. Michele Morari's co-authors include Matteo Marti, F Mela, Kjell Fuxé, Claudia L. Bianchi‬, L. Beani, Remo Guerrini, William T. O’Connor, Urban Ungerstedt, Riccardo Viaro and Claudio Trapella and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Brain.

In The Last Decade

Michele Morari

122 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michele Morari Italy	39	3.1k	2.1k	1.5k	812	322	124	4.5k
J.C. Stoof Netherlands	37	3.2k 1.0×	2.1k 1.0×	1.3k 0.9×	375 0.5×	363 1.1×	68	5.0k
Anna R. Carta Italy	32	1.5k 0.5×	983 0.5×	1.4k 0.9×	582 0.7×	147 0.5×	75	3.5k
Sarah Rose United Kingdom	35	1.9k 0.6×	974 0.5×	2.0k 1.3×	731 0.9×	455 1.4×	126	4.4k
G. Toffano Italy	40	3.4k 1.1×	2.9k 1.4×	651 0.4×	863 1.1×	615 1.9×	170	6.0k
Eric M. Parker United States	38	2.0k 0.6×	2.4k 1.2×	314 0.2×	1.1k 1.4×	145 0.5×	94	4.6k
Philippe Marin France	48	2.8k 0.9×	3.4k 1.6×	452 0.3×	1.3k 1.6×	356 1.1×	145	6.2k
Lei Yu United States	38	3.8k 1.2×	3.3k 1.6×	279 0.2×	1.7k 2.1×	372 1.2×	168	6.6k
José L. Lanciego Spain	49	3.5k 1.1×	1.9k 0.9×	2.2k 1.5×	573 0.7×	1.3k 3.9×	143	7.1k
Joseph M. Savitt United States	22	1.2k 0.4×	1.1k 0.5×	1.4k 0.9×	887 1.1×	162 0.5×	34	3.4k
Patricia K. Sonsalla United States	46	4.2k 1.3×	1.8k 0.9×	2.9k 1.9×	651 0.8×	300 0.9×	98	6.7k

Countries citing papers authored by Michele Morari

Since Specialization

Citations

This map shows the geographic impact of Michele Morari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Morari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Morari more than expected).

Fields of papers citing papers by Michele Morari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Morari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Morari. The network helps show where Michele Morari may publish in the future.

Co-authorship network of co-authors of Michele Morari

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Morari. A scholar is included among the top collaborators of Michele Morari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Morari. Michele Morari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pischedda, Francesca, Maria Daniela Cirnaru, Luisa Ponzoni, et al.. (2021). LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation. Brain. 144(5). 1509–1525. 19 indexed citations

Regoni, Maria, Stefano Comai, Daniela Mercatelli, et al.. (2021). Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse. Biomedicines. 9(5). 514–514. 4 indexed citations

Sarti, Alba Clara, Valentina Vultaggio-Poma, Simonetta Falzoni, et al.. (2021). Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance. Function. 2(2). zqab005–zqab005. 43 indexed citations

Viaro, Riccardo, Francesco Longo, Fabrizio Vincenzi, Katia Varani, & Michele Morari. (2021). l-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter. Brain Research. 1768. 147583–147583. 10 indexed citations

Bengoetxea, Harkaitz, et al.. (2020). 6‐Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata. British Journal of Pharmacology. 177(17). 3957–3974. 12 indexed citations

Russo, Isabella, Giulietta Di Benedetto, Alice Kaganovich, et al.. (2018). Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4. Journal of Neuroinflammation. 15(1). 297–297. 36 indexed citations

Novello, Salvatore, Ludovico Arcuri, Sandra Doveró, et al.. (2018). G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice. Neurobiology of Disease. 120. 21–33. 53 indexed citations

Mercatelli, Daniela, et al.. (2018). NOP Receptor Ligands and Parkinson’s Disease. Handbook of experimental pharmacology. 254. 213–232. 11 indexed citations

Sacchi, Silvia, Vito de Novellis, Giovanna Paolone, et al.. (2017). Olanzapine, but not clozapine, increases glutamate release in the prefrontal cortex of freely moving mice by inhibiting D-aspartate oxidase activity. Scientific Reports. 7(1). 46288–46288. 47 indexed citations

10.

Cristino, Luigia, Livio Luongo, Marta Squillace, et al.. (2015). d-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain. Neurobiology of Aging. 36(5). 1890–1902. 42 indexed citations

11.

Marti, Matteo, Donata Rodi, Qin Li, et al.. (2012). Nociceptin/Orphanin FQ Receptor Agonists Attenuate l-DOPA-Induced Dyskinesias. Journal of Neuroscience. 32(46). 16106–16119. 32 indexed citations

12.

Volta, Mattia, Riccardo Viaro, Claudio Trapella, Matteo Marti, & Michele Morari. (2011). Dopamine–nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity. Experimental Neurology. 228(1). 126–137. 17 indexed citations

13.

Spagnolo, Barbara, Martina Fantin, John McDonald, et al.. (2007). Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol]: In Vitro Studies. Journal of Pharmacology and Experimental Therapeutics. 321(3). 961–967. 93 indexed citations

14.

Rizzi, Anna, Remo Guerrini, Timothy Barnes, et al.. (2005). [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1114–1123. 28 indexed citations

15.

Marti, Matteo, F Mela, Remo Guerrini, et al.. (2004). RAPID COMMUNICATION: Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol‐induced akinesia and normalizes nigral glutamate release. Journal of Neurochemistry. 91(6). 1501–1504. 36 indexed citations

16.

Mela, F, Matteo Marti, Silvia Zucchini, et al.. (2004). Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5‐hydroxytryptamine release in the mouse neocortex. European Journal of Neuroscience. 19(5). 1317–1324. 36 indexed citations

17.

Marti, Matteo, Remo Guerrini, L. Beani, Claudia L. Bianchi‬, & Michele Morari. (2002). Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat. Neuroscience. 112(1). 153–160. 35 indexed citations

18.

Marti, Matteo, F Mela, Clementina Bianchi, Lorenzo Beani, & Michele Morari. (2002). Striatal dopamine–NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D₁ and D₂ receptors. Journal of Neurochemistry. 83(3). 635–644. 53 indexed citations

19.

Morari, Michele, S. Sbrenna, Matteo Marti, et al.. (1998). Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat. European Journal of Neuroscience. 10(5). 1716–1722. 14 indexed citations

20.

Morari, Michele, William T. O’Connor, Urban Ungerstedt, & Kjell Fuxé. (1994). Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by acid. European Journal of Pharmacology. 256(1). 23–30. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact